BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Clin Cases. Nov 26, 2025; 13(33): 110641
Published online Nov 26, 2025. doi: 10.12998/wjcc.v13.i33.110641
Table 1 Baseline characteristics before matching, n (%)/mean ± SD
Baseline characteristics
RA+DM (n = 60523)
RA-DM (n = 138848)
P value
Age 69.06 (11.56)68.25 (14.41)< 0.001
Gender
Female42031 (69.45)102277 (73.66)< 0.001
Race
White40840 (67.48)108904 (78.43)< 0.001
Black10059 (16.62)14765 (10.63)< 0.001
Hispanic6368 (10.52)9481 (6.83)< 0.001
Asian1375 (2.27)2718 (1.96)< 0.001
Native1196 (1.98)1999 (1.44)< 0.001
Other685 (1.13)990 (0.71)< 0.001
Comorbidities
Gastro-esophageal reflux disease21363 (35.3)46663 (33.61)< 0.001
Chronic obstructive pulmonary disease7849 (12.97)16699 (12.03)< 0.001
Asthma6271 (10.36)12672 (9.13)< 0.001
Smoking5780 (9.55)15831 (11.4)< 0.001
Heart failure29061 (48.02)38053 (27.4)< 0.001
Chronic kidney disease20373 (33.66)23650 (17.03)< 0.001
Atrial fibrillation9868 (16.3)19183 (13.81)< 0.001
Ventricular tachycardia1065 (1.76)1996 (1.44)< 0.001
Hypertension53568 (88.51)99210 (71.45)< 0.001
Obesity19604 (32.39)25059 (18.05)< 0.001
Alcohol use1132 (1.87)4936 (3.55)< 0.001
Steroids use5767 (9.53)15274 (11.0)< 0.001
Coronary artery disease21901 (36.19)31360 (22.58)< 0.001
Table 2 Baseline characteristics after matching, n (%)/mean ± SD
Baseline characteristics
RA+DM (n = 60523)
RA-DM (n = 60523)
P value
Age69.06 (11.56)69.1 (11.60)0.986
Gender
Female42031 (69.45)41985 (69.37)0.774
Race
White40840 (67.48)40910 (67.59)0.667
Black10059 (16.62)9997 (16.51)0.632
Hispanic6368 (10.52)6391 (10.55)0.830
Asian1375 (2.27)1384 (2.28)0.862
Native1196 (1.98)1149 (1.89)0.327
Other685 (1.13)692 (1.14)0.850
Comorbidities
Gastro-esophageal reflux disease21363 (35.30)21363 (35.30)1.000
Chronic obstructive pulmonary disease7849 (12.97)7833 (12.94)0.898
Asthma6271 (10.36)6268 (10.36)0.985
Smoking5780 (9.55)5761 (9.52)0.860
Heart failure29061 (48.02)29049 (48.00)0.950
Chronic kidney disease20373 (33.66)20348 (33.62)0.884
Atrial fibrillation9868 (16.30)9863 (16.30)0.975
Ventricular tachycardia1065 (1.76)1059 (1.75)0.913
Hypertension53568 (88.51)53525 (88.44)0.705
Obesity19604 (32.39)19580 (32.35)0.888
Alcohol use1132 (1.87)1129 (1.87)0.966
Steroids use5767 (9.53)5760 (9.52)0.953
Coronary artery disease21901 (36.19)21890 (36.17)0.952
Table 3 Primary outcomes after propensity matching, n (%)
Outcomes
RA+DM (n = 50423)
RA-DM (n = 50423)
P value
Interstitial lung diseases1360 (2.25)672 (1.11)< 0.001
Usual interstitial pneumonia/pulmonary fibrosis840 (1.67)227 (0.45)< 0.001
Non-specific interstitial pneumonia494 (0.98)133 (0.26)< 0.001
Eosinophilic lung disease18 (0.04)78 (0.15)< 0.001
Respiratory bronchiolitis interstitial lung disease8 (0.02)5 (0.01)< 0.001
Cryptogenic organizing pneumonia17 (0.03)1 (< 0.01)0.057
Acute interstitial pneumonitis11 (0.02)5 (0.01)< 0.001
Table 4 Primary and secondary outcomes odds ratio after multivariate regression
Outcomes
Odds ratio
P value
95%CI
Interstitial lung diseases2.203< 0.0011.843-2.219
Usual interstitial pneumonia/pulmonary fibrosis3.200< 0.0012.800-3.700
Non-specific interstitial pneumonia3.500< 0.0012.900-4.100
Eosinophilic lung disease0.232< 0.0010.112-0.415
Respiratory bronchiolitis interstitial lung disease1.6360.0020.531-5.036
Cryptogenic organizing pneumonia96.0400.060.860-1072
Acute interstitial pneumonitis2.201< 0.0010.764-6.335
Acute respiratory distress syndrome1.1160.2600.921-1.353
Pneumothorax1.848< 0.0011.465-2.332
Pleural effusion1.0280.490.959-1.101
Pulmonary arterial hypertension1.397< 0.0011.331-1.467
Table 5 Secondary outcomes after propensity matching, n (%)
Outcomes
RA+DM (n = 50423)
RA-DM (n = 50423)
P value
Acute respiratory distress syndrome221 (0.44)198 (0.39)0.260
Pneumothorax203 (0.40)110 (0.22)< 0.001
Pleural effusion1694 (3.36)1648 (3.27)0.49
Pulmonary arterial hypertension4141 (8.21)2964 (5.88)< 0.001